| 产品描述: | PF-05175157是一种广谱有效的ACC抑制剂,对人ACC1,人ACC2,大鼠ACC1和大鼠ACC2的IC50分别为27.0 nM、33.0 nM、23.5 nM和50.4 n |
| 靶点: |
rACC1(Cell-free assay):23.5 nM;hACC1(Cell-free assay):27.0 nM;hACC2(Cell-free assay):33.0 nM;rACC2(Cell-free assay):50.4 nM;Acetyl-CoACarboxylase |
| 体内研究: |
In vivo, the plasma clearance of PF-05175157 is low following intravenous (iv) administration (1 mg/kg) to rats, dogs, and monkeys. Oral (po) administration (3 mg/kg) to rats and dogs showed bioavailability of 40% and 54%, respectively, consistent with the low microsomal clearance and good solubility at low pH. The bioavailability following a 50 mg/kg oral dose in rats was 106%, suggesting saturation of clearance. Formation of the direct product of ACC, malonyl-CoA, in the skeletal muscle and liver of lean Sprague Dawley rats is assessed 1 h following an acute oral dose of PF-05175157, showing concentration-dependent reductions in both skeletal muscle and liver malonyl-CoA. At the nadir, quadriceps and liver malonyl-CoA levels are reduced by 76% and 89%, respectively. |
| 细胞实验: |
Cell lines: rat hepatocytes Concentrations: -- Incubation Time: 5 h Method: On the day of the study, media was aspirated and cells are treated with fresh MCM media containing DMSO vehicle or varying concentrations of PF-05175157 as indicated. Compound was initially dissolved in DMSO and subsequently diluted 1:100 in MCM.After 5 h at 37 °C, incubation media is removed and the experiment is terminated by washing the cells with ice cold PBS. |
| 动物实验: |
Animal Models: Male SD rats Dosages: 0.25mg/kg, 0.5mg/kg, 1mg/kg, 2mg/kg, 4mg/kg, 8mg/kg, 15mg/kg, 25mg/kg, 50mg/kg and 100 mg/kg Administration: Oral |
| 参考文献: |
1. David A Griffith,et al.J Med Chem.2014;57 (24): 10512-10526. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.466 ml |
12.331 ml |
24.662 ml |
| 5 mM |
0.493 ml |
2.466 ml |
4.932 ml |
| 10 mM |
0.247 ml |
1.233 ml |
2.466 ml |
| 50 mM |
0.049 ml |
0.247 ml |
0.493 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |